Anne Worsøe

I’m Head of Investor Relations & Communication at Ultimovacs ASA, a listed biotech company developing a therapeutic cancer vaccine (five clinical trials phase II @ 100+ hospitals in 15 countries, FDA Fast Track) as well as a novel tech platform for cancer treatment. I’m privileged to work with visionary scientists, company builders and investors, making real #impact. (OSE:ULTI)

I have experience as an executive/non-executive across multiple industries and international markets; AI & software development, biotech, renewable energy, diplomat/foreign affairs, finance/vc and management consulting. I have served on the boards of several private and public limited companies, early-stage companies and venture capital funds.